Investing.com — In a recent report, Bank of America revealed the top 10 stocks most widely held by funds globally, highlighting their
Investing.com — The debate over whether TikTok will be banned in the United States has reached a critical juncture, with developments raising
By Aditya Kalra NEW DELHI (Reuters) – India’s Religare Enterprises (NSE:RELG) said a U.S. businessman has made a proposal to acquire
The nomination of Gov. Kristi Noem, R-S.D., to be the next Homeland Security secretary defeated a key hurdle in the confirmation process
The Senate voted to confirm President Donald Trump’s nominee, Pete Hegseth, as defense secretary on Friday night after a high-tempered battle to
By Kanishka Singh WASHINGTON (Reuters) – U.S. President Donald Trump’s administration asked U.S. federal agencies on Friday to terminate roles and offices related
Secretary of State Marco Rubio told Chinese Foreign Minister and Director of the CCP Central Foreign Affairs Commission Wang Yi that the
By Jody Godoy (Reuters) – The chairman of the Federal Trade Commission on Friday acknowledged staff anxiety over returning to full-time in the
(Reuters) – Global ratings agency Moody’s (NYSE:MCO) revised Kenya’s outlook to “positive” from “negative” on Friday, citing a potential ease in liquidity
(Reuters) – Ratings agency Moody’s (NYSE:MCO) on Friday raised Argentina’s long-term foreign currency sovereign credit rating to “Caa3” from “Ca”, citing the
Investing.com — Surging equity markets look set to persist, supported by solid U.S.-led economic growth, but this growth is likely to come
(Reuters) – The cyberattack at UnitedHealth’s tech unit Change affected the personal information of 190 million Americans, TechCrunch reported on Friday. UnitedHealth Group
By Jonathan Stempel NEW YORK (Reuters) – Pfizer (NYSE:PFE) will pay $59.7 million to resolve charges that a company it acquired
By Jessica DiNapoli and Jonathan Stempel NEW YORK (Reuters) – Ben & Jerry’s on Friday ratcheted up its censorship lawsuit against Unilever
By Dietrich Knauth NEW YORK (Reuters) – Purdue Pharma said on Friday it needs more time to build support for a new $7.4
By Tim McLaughlin and Laila Kearney (Reuters) – President Donald Trump’s oversight of an increasingly unreliable U.S. power grid requires swift action, he
